What is the main purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report Axon Enterprise, Inc.'s entry into a new distribution agreement, which establishes an "at the market" equity offering program. This allows the company to sell up to 1,954,450 previously registered but unsold shares of its common stock.

How much capital can Axon potentially raise from this offering?

The maximum potential capital raise is based on the sale of 1,954,450 shares. The exact amount will depend on the market price at which these shares are sold, less the agent's commission. This offering is opportunistic, and Axon is not obligated to sell any shares.

What will the proceeds from any share sales be used for?

Axon intends to use the net proceeds from any sales for general corporate purposes. This includes satisfying tax obligations related to employee stock compensation, supporting its growth, and potentially acquiring products, services, technologies, or facilities.

Does Axon have to sell these shares?

No, Axon has no obligation to sell any of the shares under this program. The company retains the flexibility to decide whether to sell, how many shares to sell, and when to sell them, and can suspend or terminate the agreement at any time.

AXON 8-K: Material Agreements

Summary

Axon Enterprise, Inc. has filed an 8-K report detailing the establishment of a new "at the market" equity offering program. This program allows Axon to sell up to 1,954,450 shares of its common stock, which were unsold from a previous offering that expired on April 20, 2024. The shares will be sold through J.P. Morgan Securities LLC as the agent, with Axon retaining the discretion to determine the timing and amounts of any sales. The company intends to use the net proceeds for general corporate purposes, including funding tax obligations related to stock compensation, supporting growth initiatives, and potential acquisitions. This filing indicates Axon's strategy to potentially raise capital through the sale of existing registered shares. Investors should note that the company is not obligated to sell any shares and can suspend or terminate the program at any time. The agreement with the agent includes a commission of up to 2% on gross sales. The overall capacity for this offering is modest relative to Axon's market capitalization, suggesting it's a flexible tool for opportunistic capital raising rather than a significant financing event.

Key Highlights

1Axon has entered into a new Distribution Agreement with J.P. Morgan Securities LLC to sell up to 1,954,450 shares of common stock.
2These shares represent the unsold balance from a previous "at the market" equity offering that expired in April 2024.
3The offering allows Axon to sell shares from time to time as determined by the company and agreed upon with the agent.
4Axon is not obligated to sell any shares and can suspend or terminate the offering at any time.
5The net proceeds from any sales will be used for general corporate purposes, including tax obligations from stock awards, growth initiatives, and potential acquisitions.
6The selling agent, J.P. Morgan Securities LLC, will receive compensation not exceeding 2% of the gross sales price.
7Sales will be made on the Nasdaq Global Select Market or through other agreed-upon methods at prevailing market prices or negotiated prices.

AXON ENTERPRISE, INC. 8-K Report, Material Agreement (May 13, 2024)

Summary

Key Highlights

Frequently Asked Questions